We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Impact of Raltegravir on HIV-1 cDNA Slope Following Antiretroviral Therapy (ART) Initiation

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01168167
First Posted: July 23, 2010
Last Update Posted: March 23, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
University Hospital Heidelberg
Information provided by (Responsible Party):
Christoph Stephan, Johann Wolfgang Goethe University